Metformin's Impact on Molecular Aging Markers in Prediabetes Patients
Background
Prediabetes affects millions globally, significantly increasing the risk of developing type 2 diabetes and associated complications. Beyond metabolic dysfunction, prediabetes is also increasingly linked to accelerated biological aging processes. While metformin is a cornerstone treatment for prediabetes, its specific effects on molecular markers of aging, such as leukocyte telomere length and longevity gene expression, remain under-investigated in North Indian populations.
Results
This completed randomized controlled trial, involving 112 participants over a 6-month period, aimed to investigate the effects of metformin on molecular aging markers in individuals with prediabetes. The study's primary objective was to quantify potential changes in leukocyte telomere length (LTL) and telomerase activity, as well as the expression levels of specific longevity-associated genes. Researchers planned to analyze gene expression for Sirtuin 1, p66Shc, p53, and mTOR using qPCR, expecting to observe potential modulations indicative of anti-aging effects. While the study is complete, specific quantitative results detailing the impact on telomere length or gene expression are not yet publicly available from this record. The core focus was to determine if metformin treatment could significantly alter these biomarkers of aging in individuals with prediabetes compared to a placebo group.
Why It Matters
This study is crucial for understanding the pleiotropic effects of metformin beyond its well-known glucose-lowering capabilities, specifically its potential role in modulating molecular aging processes in prediabetes. If metformin demonstrates a significant positive impact on telomere length or longevity gene expression, it could reposition metformin as a therapeutic agent with anti-aging properties, potentially extending healthy lifespan in at-risk populations. Future steps would involve the publication of these results, followed by potential larger-scale studies or meta-analyses to confirm these findings and explore broader clinical applications.